PatenSee
Active
Clinical Detection Disease
Artificial Intelligence Machine Learning

Business Overview

DESCRIPTION

PatenSee is developing a novel machine-learning-based surveillance tool for end-stage renal disease (ESRD) patients who are on hemodialysis treatment. PatenSee’s solution is being developed to seamlessly integrate into the clinic workflow and detect early signs of vascular access stenosis to allow preventative, and less costly, intervention. Early detection will help the patient avoid costly procedures and complications such as infection and minimize dialysis treatment interruption.

PatenSee was founded by Hagay Drori following his participation in MEDX Xelerator’s X-Challenge competition, the incubator’s initiative to create promising medical device startups developing breakthrough solutions that can impact patients’ lives and improve healthcare systems.

FOUNDED
March 2019
EMPLOYEES
4
BUSINESS MODEL
B2B
OFFERING TYPE
Software
SECTORS
Clinical Detection Disease Healthcare Prevention Workflow

Founders

Gal Goshen
CEO

Board Members and Advisors

PatenSee
Shay Policker
Board Member

Funding Rounds

Date Announced

Funding Round

Amount Raised

Investors

AI Technology Stack

AI APPLICATION
Vertical AI
AI TYPES
Artificial Intelligence Machine Learning